FSLBX
Price
$190.92
Change
+$1.36 (+0.72%)
Updated
Nov 12 closing price
Net Assets
1.28B
RYFCX
Price
$75.18
Change
+$0.36 (+0.48%)
Updated
Nov 12 closing price
Net Assets
10.25M
Interact to see
Advertisement

FSLBX vs RYFCX

Header iconFSLBX vs RYFCX Comparison
Open Charts FSLBX vs RYFCXBanner chart's image
Fidelity Select Brokerage & Inv Mgmt
Price$190.92
Change+$1.36 (+0.72%)
VolumeN/A
Net Assets1.28B
Rydex Financial Services C
Price$75.18
Change+$0.36 (+0.48%)
VolumeN/A
Net Assets10.25M
FSLBX vs RYFCX Comparison Chart in %
View a ticker or compare two or three
VS
FSLBX vs. RYFCX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSLBX is a Buy and RYFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSLBX has more cash in the bank: 1.28B vs. RYFCX (10.3M). RYFCX pays higher dividends than FSLBX: RYFCX (0.99) vs FSLBX (0.67). FSLBX was incepted earlier than RYFCX: FSLBX (40 years) vs RYFCX (25 years). RYFCX (2.44) is less costly to investors than FSLBX (0.69). RYFCX is a more actively managed with annual turnover of: 280.00 vs. FSLBX (16.00). FSLBX has a lower initial minimum investment than RYFCX: FSLBX (0) vs RYFCX (2500). RYFCX annual gain was more profitable for investors over the last year : 4.09 vs. FSLBX (1.43). FSLBX return over 5 years is better than : 127.97 vs. RYFCX (33.20).
FSLBXRYFCXFSLBX / RYFCX
Total Expense Ratio0.692.3929%
Annual Report Gross Expense Ratio0.692.4428%
Fund Existence40 years25 years-
Gain YTD4.3858.62651%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.28B10.3M12,437%
Annual Yield % from dividends0.670.9968%
Returns for 1 year1.434.0935%
Returns for 3 years67.938.55795%
Returns for 5 years127.9733.20385%
Returns for 10 years189.2768.46276%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE63.100.15
+0.24%
Apogee Therapeutics
SMID37.83N/A
N/A
Smith-Midland Corp
TTWO240.34-0.36
-0.15%
Take-Two Interactive Software
ATUS1.96-0.01
-0.51%
Altice USA
NINE0.47-0.04
-8.09%
Nine Energy Service